• 1
    Gibbs RS, Romero R, Hillier SL, Eschenbach DA & Sweet RL (1992) A review of premature birth and subclinical infection. Am J Obstet Gynecol 166, 15151528.
  • 2
    Hirsch E, Saotome I & Hirsh D (1995) A model of intrauterine infection and preterm delivery in mice. Am J Obstet Gynecol 172, 15981603.
  • 3
    Krohn MA, Hillier SL, Nugent RP, Cotch MF, Carey JC, Gibbs RS & Eschenbach DA (1995) The genital flora of women with intraamniotic infection. Vaginal Infection and Prematurity Study Group. J Infect Dis 171, 14751480.
  • 4
    Nowicki B, Fang L, Singhal J, Nowicki S & Yallampalli C (1997) Lethal outcome of uterine infection in pregnant but not in nonpregnant rats and increased death rate with inhibition of nitric oxide. Am J Reprod Immunol 38, 309312.
  • 5
    Nowicki B, Singhal J, Fang L, Nowicki S & Yallampalli C (1999) Inverse relationship between severity of experimental pyelonephritis and nitric oxide production in C3H/HeJ mice. Infect Immun 67, 24212427.
  • 6
    Fang L, Nowicki BJ, Dong YL & Yallampalli C (1999) Localized increase in nitric oxide production and the expression of nitric oxide synthase isoforms in rat uterus with experimental intrauterine infection. Am J Obstet Gynecol 181, 601609.
  • 7
    Hart A, Pham T, Nowicki S, Whorton EB Jr, Martens MG, Anderson GD & Nowicki BJ (1996) Gestational pyelonephritis-associated Escherichia coli isolates represent a nonrandom, closely related population. Am J Obstet Gynecol 174, 983989.
  • 8
    Hart A, Nowicki BJ, Reisner B, Pawelczyk E, Goluszko P, Urvil P, Anderson G & Nowicki S (2001) Ampicillin-resistant Escherichia coli in gestational pyelonephritis: increased occurrence and association with the colonization factor Dr adhesin. J Infect Dis 183, 15261529.
  • 9
    Goluszko P, Popov V, Selvarangan R, Nowicki S, Pham T & Nowicki BJ (1997) Dr fimbriae operon of uropathogenic Escherichia coli mediate microtubule-dependent invasion to the HeLa epithelial cell line. J Infect Dis 176, 158167.
  • 10
    Nowicki B, Hart A, Coyne KE, Lublin DM & Nowicki S (1993) Short consensus repeat-3 domain of recombinant decay-accelerating factor is recognized by Escherichia coli recombinant Dr adhesin in a model of a cell–cell interaction. J Exp Med 178, 21152121.
  • 11
    Selvarangan R, Goluszko P, Popov V, Singhal J, Pham T, Lublin DM, Nowicki S & Nowicki B (2000) Role of decay-accelerating factor domains and anchorage in internalization of Dr-fimbriated Escherichia coli. Infect Immun 68, 13911399.
  • 12
    Fang L, Nowicki BJ, Urvil P, Goluszko P, Nowicki S, Young SL & Yallampalli C (2004) Epithelial invasion by Escherichia coli bearing Dr fimbriae is controlled by nitric oxide-regulated expression of CD55. Infect Immun 72, 29072914.
  • 13
    Thomas DJ & Lublin DM (1993) Identification of 5′-flanking regions affecting the expression of the human decay accelerating factor gene and their role in tissue-specific expression. J Immunol 150, 151160.
  • 14
    Kaul A, Nagamani M & Nowicki B (1995) Decreased expression of endometrial decay accelerating factor (DAF), a complement regulatory protein, in patients with luteal phase defect. Am J Reprod Immunol 34, 236240.
  • 15
    Parker CJ (1996) Molecular basis of paroxysmal nocturnal hemoglobinuria. Stem Cells 14, 396411.
  • 16
    Murray KP, Mathure S, Kaul R, Khan S, Carson LF, Twiggs LB, Martens MG & Kaul A (2000) Expression of complement regulatory proteins – CD 35, CD 46, CD 55, and CD 59 – in benign and malignant endometrial tissue. Gynecol Oncol 76, 176182.
  • 17
    Niehans GA, Cherwitz DL, Staley NA, Knapp DJ & Dalmasso AP (1996) Human carcinomas variably express the complement inhibitory proteins CD46 (membrane cofactor protein), CD55 (decay-accelerating factor), and CD59 (protectin). Am J Pathol 149, 129142.
  • 18
    Ahmad SR, Lidington EA, Ohta R, Okada N, Robson MG, Davies KA, Leitges M, Harris CL, Haskard DO & Mason JC (2003) Decay-accelerating factor induction by tumour necrosis factor-alpha, through a phosphatidylinositol-3 kinase and protein kinase C-dependent pathway, protects murine vascular endothelial cells against complement deposition. Immunology 110, 258268.
  • 19
    Andoh A, Fujiyama Y, Sumiyoshi K, Sakumoto H, Okabe H & Bamba T (1997) Tumour necrosis factor-alpha up-regulates decay-accelerating factor gene expression in human intestinal epithelial cells. Immunology 90, 358363.
  • 20
    Nasu J, Mizuno M, Uesu T, Takeuchi K, Inaba T, Ohya S, Kawada M, Shimo K, Okada H, Fujita T, et al. (1998) Cytokine-stimulated release of decay-accelerating factor (DAF;CD55) from HT-29 human intestinal epithelial cells. Clin Exp Immunol 113, 379385.
  • 21
    Young SL, Lessey BA, Fritz MA, Meyer WR, Murray MJ, Speckman PL & Nowicki BJ (2002) In vivo and in vitro evidence suggest that HB-EGF regulates endometrial expression of human decay-accelerating factor. J Clin Endocrinol Metab 87, 13681375.
  • 22
    Wang S, Wang W, Wesley RA & Danner RL (1999) A Sp1 binding site of the tumor necrosis factor alpha promoter functions as a nitric oxide response element. J Biol Chem 274, 3319033193.
  • 23
    Lee KA & Masson N (1993) Transcriptional regulation by CREB and its relatives. Biochim Biophys Acta 1174, 221233.
  • 24
    Barreau C, Paillard L & Osborne HB (2005) AU-rich elements and associated factors: are there unifying principles? Nucleic Acids Res 33, 71387150.
  • 25
    Lafarga V, Cuadrado A, Lopez de Silanes I, Bengoechea R, Fernandez-Capetillo O & Nebreda AR (2009) p38 Mitogen-activated protein kinase- and HuR-dependent stabilization of p21(Cip1) mRNA mediates the G(1)/S checkpoint. Mol Cell Biol 29, 43414351.
  • 26
    Andoh A, Shimada M, Araki Y, Fujiyama Y & Bamba T (2002) Sodium butyrate enhances complement-mediated cell injury via down-regulation of decay-accelerating factor expression in colonic cancer cells. Cancer Immunol Immunother 50, 663672.
  • 27
    Cummings JH (1981) Short chain fatty acids in the human colon. Gut 22, 763779.
  • 28
    Daniel P, Brazier M, Cerutti I, Pieri F, Tardivel I, Desmet G, Baillet J & Chany C (1989) Pharmacokinetic study of butyric acid administered in vivo as sodium and arginine butyrate salts. Clin Chim Acta 181, 255263.
  • 29
    Banadakoppa M, Goluszko P, Liebenthal D & Yallampalli C (2012) Nitric oxide induces segregation of decay accelerating factor (DAF or CD55) from the membrane lipid-rafts and its internalization in human endometrial cells. Cell Biol Int 36, 901907.
  • 30
    Ewulonu UK, Ravi L & Medof ME (1991) Characterization of the decay-accelerating factor gene promoter region. Proc Natl Acad Sci USA 88, 46754679.
  • 31
    Cauvi DM, Cauvi G & Pollard KM (2006) Constitutive expression of murine decay-accelerating factor 1 is controlled by the transcription factor Sp1. J Immunol 177, 38373847.
  • 32
    De LA, Sacchetta P, Nieddu M, Di IC & Favaloro B (2007) Important roles of multiple Sp1 binding sites and epigenetic modifications in the regulation of the methionine sulfoxide reductase B1 (MsrB1) promoter. BMC Mol Biol 8, 39.
  • 33
    Ji C, Casinghino S, McCarthy TL & Centrella M (1997) Multiple and essential Sp1 binding sites in the promoter for transforming growth factor-beta type I receptor. J Biol Chem 272, 2126021267.
  • 34
    Chu S & Ferro TJ (2005) Sp1: regulation of gene expression by phosphorylation. Gene 348, 111.
  • 35
    Berendji D, Kolb-Bachofen V, Meyer KL, Grapenthin O, Weber H, Wahn V & Kroncke KD (1997) Nitric oxide mediates intracytoplasmic and intranuclear zinc release. FEBS Lett 405, 3741.
  • 36
    Gruber AR, Fallmann J, Kratochvill F, Kovarik P & Hofacker IL (2011) AREsite: a database for the comprehensive investigation of AU-rich elements. Nucleic Acids Res 39, D66D69.
  • 37
    Nishikawa Y (1985) Adherence of Escherichia coli in pathogenesis of endometritis and effects of estradiol examined by scanning electron microscopy. Infect Immun 47, 318321.
  • 38
    Nishikawa Y & Baba T (1985) In vitro adherence of Escherichia coli to endometrial epithelial cells of rats and influence of estradiol. Infect Immun 50, 506509.
  • 39
    Holcik M & Liebhaber SA (1997) Four highly stable eukaryotic mRNAs assemble 3′ untranslated region RNA–protein complexes sharing cis and trans components. Proc Natl Acad Sci USA 94, 24102414.
  • 40
    Ostareck DH, Ostareck-Lederer A, Wilm M, Thiele BJ, Mann M & Hentze MW (1997) mRNA silencing in erythroid differentiation: hnRNP K and hnRNP E1 regulate 15-lipoxygenase translation from the 3′ end. Cell 89, 597606.
  • 41
    Wang S, Zhang J, Theel S, Barb JJ, Munson PJ & Danner RL (2006) Nitric oxide activation of Erk1/2 regulates the stability and translation of mRNA transcripts containing CU-rich elements. Nucleic Acids Res 34, 30443056.
  • 42
    Akool el S, Kleinert H, Hamada FM, Abdelwahab MH, Forstermann U, Pfeilschifter J & Eberhardt W (2003) Nitric oxide increases the decay of matrix metalloproteinase 9 mRNA by inhibiting the expression of mRNA-stabilizing factor HuR. Mol Cell Biol 23, 49014916.
  • 43
    Kuwano Y, Rabinovic A, Srikantan S, Gorospe M & Demple B (2009) Analysis of nitric oxide-stabilized mRNAs in human fibroblasts reveals HuR-dependent heme oxygenase 1 upregulation. Mol Cell Biol 29, 26222635.
  • 44
    Kim HH, Abdelmohsen K & Gorospe M (2010) Regulation of HuR by DNA damage response kinases. J Nucleic Acids 25, 18.
  • 45
    Kim S & Ponka P (2003) Role of nitric oxide in cellular iron metabolism. Biometals 16, 125135.
  • 46
    Liu W, Rosenberg GA & Liu KJ (2006) AUF-1 mediates inhibition by nitric oxide of lipopolysaccharide-induced matrix metalloproteinase-9 expression in cultured astrocytes. J Neurosci Res 84, 360369.
  • 47
    Nishida M, Kasahara K, Kaneko M, Iwasaki H & Hayashi K (1985) Establishment of a new human endometrial adenocarcinoma cell line, Ishikawa cells, containing estrogen and progesterone receptors. Nippon Sanka Fujinka Gakkai Zasshi 37, 11031111.
  • 48
    Kuwano Y, Pullmann R Jr, Marasa BS, Abdelmohsen K, Lee EK, Yang X, Martindale JL, Zhan M & Gorospe M (2010) NF90 selectively represses the translation of target mRNAs bearing an AU-rich signature motif. Nucleic Acids Res 38, 225238.
  • 49
    Pan YX, Chen H & Kilberg MS (2005) Interaction of RNA-binding proteins HuR and AUF1 with the human ATF3 mRNA 3′-untranslated region regulates its amino acid limitation-induced stabilization. J Biol Chem 280, 3460934616.
  • 50
    Fialcowitz-White EJ, Brewer BY, Ballin JD, Willis CD, Toth EA & Wilson GM (2007) Specific protein domains mediate cooperative assembly of HuR oligomers on AU-rich mRNA-destabilizing sequences. J Biol Chem 282, 2094820959.
  • 51
    Jaffrey SR & Snyder SH (2001) The biotin switch method for the detection of S-nitrosylated proteins. Sci STKE 2001, pl1. doi: 10.1126/stke.2001.86.pl1